Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-06-26 | KALA BIO, Inc. | Bazemore Todd
(SEE REMARKS) |
S | Common Stock | D | 4653 | $4.75 - $4.75 | $22,101 |
| 2024-06-26 | KALA BIO, Inc. | Kharabi Darius
(CHIEF BUSINESS OFFICER) |
S | Common Stock | D | 5158 | $4.75 - $4.75 | $24,500 |
| 2024-06-26 | KALA BIO, Inc. | Reumuth Mary
(CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 4163 | $4.75 - $4.75 | $19,774 |
| 2024-06-26 | KALA BIO, Inc. | Iwicki Mark T
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 15168 | $4.75 - $4.75 | $72,048 |
| 2024-06-26 | KALA BIO, Inc. | Brazzell Romulus K
(SEE REMARKS) |
S | Common Stock | D | 5489 | $4.75 - $4.75 | $26,072 |
| 2024-06-11 | KALA BIO, Inc. | Rosen Howard B
(Director) |
A | Common Stock | A | 1400 | $0.00 - $0.00 | $0 |
| 2024-06-11 | KALA BIO, Inc. | Farid Marjan
(Director) |
A | Common Stock | A | 1400 | $0.00 - $0.00 | $0 |
| 2024-06-11 | KALA BIO, Inc. | PERRY GREGORY D
(Director) |
A | Common Stock | A | 1400 | $0.00 - $0.00 | $0 |
| 2024-06-11 | KALA BIO, Inc. | Myers C. Daniel
(Director) |
A | Common Stock | A | 1400 | $0.00 - $0.00 | $0 |
| 2024-06-11 | KALA BIO, Inc. | KOVEN ANDREW I
(Director) |
A | Common Stock | A | 1750 | $0.00 - $0.00 | $0 |
| 2024-06-11 | KALA BIO, Inc. | Blumenkranz Mark S.
(Director) |
A | Common Stock | A | 1400 | $0.00 - $0.00 | $0 |
| 2024-05-31 | KALA BIO, Inc. | Bazemore Todd
(SEE REMARKS) |
S | Common Stock | D | 2093 | $6.09 - $6.09 | $12,746 |
| 2024-05-31 | KALA BIO, Inc. | Kharabi Darius
(CHIEF BUSINESS OFFICER) |
S | Common Stock | D | 231 | $6.09 - $6.09 | $1,406 |
| 2024-05-31 | KALA BIO, Inc. | Reumuth Mary
(CHIEF FINANCIAL OFFICER) |
S | Common Stock | D | 1786 | $6.09 - $6.09 | $10,876 |
| 2024-05-31 | KALA BIO, Inc. | Brazzell Romulus K
(SEE REMARKS) |
S | Common Stock | D | 2002 | $6.09 - $6.09 | $12,192 |
| 2024-05-31 | KALA BIO, Inc. | Iwicki Mark T
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 7392 | $6.09 - $6.09 | $45,017 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |